Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular permeability increasing factor (VPF) in IgA nephropathy

W W Bakker, J R Beukhof, W H van Luijk

    Clinical Nephrology
    |October 1, 1982
    PubMed
    Summary

    Peripheral blood mononuclear cells from IgA nephropathy and minimal change disease patients produced vascular permeability increasing factor (VPF). This suggests altered T-cell function, not a direct link to glomerular permeability.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    OS053. Trophoblast invasion in the mesometrial triangle of atp infused pregnant rats.

    Pregnancy hypertension·2015
    Same author

    P6. Active and inactivated hemopexin in pregnancy and preeclampsia: Do they activate monocytes and endothelial cells?

    Pregnancy hypertension·2015
    Same author

    Extracellular ATP decreases trophoblast invasion, spiral artery remodeling and immune cells in the mesometrial triangle in pregnant rats.

    Placenta·2014
    Same author

    Platelets and ectonucleotidases.

    Platelets·2010
    Same author

    Reversible cardiac valvular disease in catastrophic antiphospholipid syndrome.

    The Netherlands journal of medicine·2010
    Same author

    An aid to the diagnosis of genetic disorders underlying adult-onset renal failure: a literature review.

    Clinical nephrology·2010

    Area of Science:

    • Nephrology
    • Immunology
    • Cell Biology

    Background:

    • Glomerulopathies are kidney diseases affecting the glomeruli.
    • Vascular permeability increasing factor (VPF) is implicated in vascular changes.
    • Altered immune cell function may contribute to kidney disease pathogenesis.

    Purpose of the Study:

    • To investigate the in vitro production of VPF by peripheral blood mononuclear cells (PBC) from patients with various glomerulopathies.
    • To determine if VPF production correlates with disease state (nephrotic vs. non-nephrotic) or specific kidney conditions.
    • To explore potential links between VPF production and T-cell function in IgA nephropathy and minimal change disease.

    Main Methods:

    • Peripheral blood mononuclear cells (PBC) were isolated from patients with IgA nephropathy, minimal change disease (MCD), membranous nephropathy (MGN), and healthy donors.

    Related Experiment Videos

  • PBC were stimulated in vitro with Concanavalin-A (Con-A).
  • Vascular permeability was assessed in vivo using an Evans blue assay in Wistar rats injected with cell culture supernatants.

    • Main Results:

    • Stimulated PBC from non-nephrotic IgA nephropathy patients and nephrotic MCD patients produced VPF.
    • PBC from nephrotic membranous nephropathy (MGN) patients and healthy donors did not produce VPF.
    • VPF production was observed in vitro, but no direct relationship was found between VPF and increased glomerular permeability.

    Conclusions:

    • VPF production by stimulated PBC in IgA nephropathy and MCD may indicate altered T-cell function in these conditions.
    • The study differentiates VPF production from direct glomerular permeability in these nephrotic syndromes.
    • Further research into T-cell dysregulation in glomerulopathies is warranted.